AstraZeneca settles for $520 million following investigation into improper marketing of anti-psychotic drug

Share this article:

Pharmaceutical giant AstraZeneca has agreed to pay $520 million to end a federal investigation into its alleged illegal marketing of the drug Seroquel for off-label uses, according to reports from Washington.

The Justice Department has accused AstraZeneca of misleading physicians by emphasizing research favorable to Seroquel, and downplaying potentially dangerous side effects, such as diabetes and increased risk of death for elderly patients with dementia, according to The New York Times. Though it is not illegal to use drugs for off-label purposes, it is illegal to market them for those uses. A 2009 study found that as many as 20% of physicians who prescribed Seroquel for dementia treatment were unaware that the drug hadn't been approved for that use. (McKnight's, 8/26/09)

In October of last year, AstraZeneca set aside $520 million in an agreement with the United States attorney in Philadelphia, according to the Times. AstraZeneca made $4.9 billion in sales of Seroquel in 2009. The company has denied all allegations of wrongdoing. Off-label refers to the practice of prescribing a drug for a purpose other than what it was approved for by the Food and Drug Administration.

Share this article:

More in News

Nursing home did not warn worker who was taken hostage in active ...

A nurse at a Life Care Centers of America facility in Colorado was not notified that she would be threatened and taken hostage by a gunman as part of an active shooter drill, according to a lawsuit filed Tuesday.

Revisions to False Claims Act urged by former deputy AG

A panel of witnesses debated the merits of the False Claims Act before a Judiciary subcommittee meeting Wednesday, with one former attorney general arguing current policy provokes unfair litigation and "coercive" settlements.

Medicare SNF rate finalized, reimbursements to increase by $750 million next year

Medicare SNF rate finalized, reimbursements to increase by ...

Medicare skilled nursing facility reimbursements will increase by $750 million next year under a final payment rule announced Thursday by the Centers for Medicare & Medicaid Services.